Legal & General Group’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-329
Closed -$1.85K 3561
2023
Q1
$1.85K Hold
329
﹤0.01% 3353
2022
Q4
$2.73K Hold
329
﹤0.01% 3381
2022
Q3
$11K Sell
329
-263
-44% -$9.75K ﹤0.01% 3330
2022
Q2
$24K Buy
+592
New +$43.2K ﹤0.01% 3183

Other funds holding SNCE

Legal & General Group's SNCE Position: Q2 2023 in Review

Legal & General Group sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q2 2023, closing a stake of 329 shares — an estimated $1.85K sold.

Legal & General Group first reported a position in SNCE in Q2 2022 and held it in 4 quarters. The position peaked at $24K in Q2 2022. 51 funds tracked by Wall St. Rank hold SNCE as of Q2 2023.

  • Legal & General Group reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Legal & General Group sold 329 Science 37 Holdings, Inc. Common Stock shares in Q2 2023, an estimated $1.85K.
  • Legal & General Group first reported a position in Science 37 Holdings, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • Legal & General Group's Science 37 Holdings, Inc. Common Stock position peaked at $24K in Q2 2022.
  • 51 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q2 2023.

Based on Legal & General Group's 13F filing for Q2 2023, filed 14 Aug 2023.